L-Tyrosine 500 mg
Natural health product licensed in Canada
- Licence holder
- SISU
- NPN or DIN-HM
- 80000138
- Status
- Inactive licence
- Licence date
- 21 October 2004
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Acide (S)-alpha-amino-4-hydroxybenzènepropanoïque | 500 mg | Not calculated |
Non-medicinal ingredients
Hypromellose, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Capsule | 3 Tous les jours |
Uses authorised in Canada
Helps in the management of some forms of stress (physical, psychological, sleep depravation, multitasking, etc.).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practioner if you have hyperthyroidism or Grave's Disease. Consult a health care practioner if you are taking dopamine, thyroid hormone medication and/or contraceptive medications.
- Contre-indications
Do not use if you are pregnant or breastfeeding. Discontinue if you experience nausea, headache, fatigue, heartburn or joint pain.
- Effets indésirables connus
None known.
Source
Official Health Canada record, licence 80000138
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.